HIT Consultant February 22, 2024
What You Should Know:
– Reprieve Cardiovascular, a pioneer in personalized fluid management for acute decompensated heart failure (ADHF) emerges from stealth launching with $42M in Series A financing round.
– The Series A round was co-led by Lightstone Ventures and Sante Ventures with participation from Deerfield Management, Genesis Capital, and Arboretum Ventures, will fuel the company’s clinical development programs and accelerate its mission to improve patient outcomes and reduce hospital readmissions for ADHF patients.
Addressing a Critical Need
Over 6.7 million Americans suffer from heart failure, with ADHF exacerbations leading to over a million hospital admissions annually. Frequent readmissions and prolonged hospital stays pose significant burdens on patients, healthcare systems, and costs. Reprieve’s intelligent fluid management system aims to...
Today's Sponsors
Today's Sponsor